Interaction between Inhaled Nitric Oxide and Intravenous Sildenafil in A Porcine Model of Meconium Aspiration Syndrome

Pediatric Research

Volumn 55, Issue 3, 2004, Pages 413-418

  Shekerdemian, Lara S ^a   Ravn, Hanne B ^b   Penny, Daniel J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ACUTE DISEASE; AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE; DETERIORATION; DISEASE MODEL; DOSE RESPONSE; DRUG CROSS REACTIVITY; HEART OUTPUT; HUMAN; HYPOXEMIA; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG PARENCHYMA; LUNG VASCULAR RESISTANCE; MECONIUM ASPIRATION; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SWINE; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MECONIUM ASPIRATION SYNDROME; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SWINE;

EID: 1242319516     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000112033.81970.C2     Document Type: Article

References (22)

1. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M 2001 Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544-548
2. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP 2000 Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 342:469-474
3. Hasuda T, Satoh T, Shimouchi A, Sakamaki F, Kyotani S, Matsumoto T, Goto Y, Nakanishi N 2000 Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension. Circulation 10:2066-2070
4. Goldman AP, Delius RE, Deanfield JE, de Leval MR, Sigston PE, Macrae DJ 1996 Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension. Ann Thorac Surg 62:750-755
5. Dukarm RC, Russell JA, Morin FC III, Perry BJ, Steinhorn RH 1999 The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation. Am J Respir Crit Care Med 160:858-865
6. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR 2001 Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104:424-428
7. Prasad S, Wilkinson J, Gatzoulis MA 2000 Sildenafil in primary pulmonary hypertension. N Engl J Med 343:1342
8. Abrams D, Schulze-Neick I, Magee AG 2000 Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4
9. Bigatello LM, Hess D, Dennehy KC, Medoff BD, Hurford WE 2000 Sildenafil can increase the response to inhaled nitric oxide. Anesthesiology 92:1827-1829
10. Atz AM, Lefler AK, Fairbrother DL, Uber WE, Bradley SM 2002 Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 124:628-629
11. Atz AM, Wessel DL 1999 Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91:307-310
12. Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers the pulmonary vascular resistance in a model of neonatal meconium aspiration. Am J Respir Crit Care Med 165:1098-1102
13. Mercier JC, Lacaze T, Storme L, Roze JC, Dinh-Xuan AT, Dehan M 1998 Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Eur J Pediatr 157:747-752
14. Thusu KG, Morin FC 3rd, Russell JA, Steinhorn RH 1995 The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 152:1605-1610
15. Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, Zapol WM 2000 Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92:1702-1712
16. Thebaud B, Saizou C, Famoux C, Hartman JF, Mercier JC 1999 Dypiridamole, a cGMP phosphodiestemse inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. Intensive Care Med 25:300-303
17. Adrie C, Holzmann A, Hirani WM, Zapol WM, Hurford WE 2000 Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome. Anesthesiology 93:422-430
18. Kleinsasser A, Loeckinger A, Hoermann C, Puehringer F, Mutz N, Bartsch G, Lindner KH 2001 Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med 163:339-343
19. Dukarm RC, Morin FC 3rd, Russell JA, Steinhorn RH 1998 Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension. Pediatr Res 44:831-837
20. Finer NN, Barrington KJ 2001 Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev (4):CD000399
21. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hubler M, Butrous G, Petros A, Lange P, Redington AN 2003 Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 180:II167-II173
22. Walker DK, Ackland MJ, James GC, Muirhead GJ, Rance DJ, Wastall P, Wright PA 1999 Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica 29:297-310